Form D · Other Health Care
Adeo Health Science, Inc.
Boston, MA · CIK 0001645127
Offering snapshot reported Sep 22, 2017 · SEC filing
- Reported sold
- $3.08M Offering amount: $3.08M
- Investors reported
- 21 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 11, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 22, 2017 | Initial | $3,078,553 | No comparison | 21 | SEC filing |
| Jun 1, 2016 | Initial | $2,019,751 | No comparison | 21 | SEC filing |
| Jun 19, 2015 | Initial | $265,000 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-295257
Source: Form D, filed Sep 22, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Clarence Friedman | Director, Executive |
| Peter Kolchinsky | Director |
| Adam Rosenberg | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
398 Columbus Avenue, Pmb 291
Boston, MA, 02116
Boston, MA, 02116